Loading…
Lobbying Spend
—
Filings
48
Firms Hired
1
Active Period
2016–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Accelerating Kids’ Access to Care Act of 2025
2026 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1509
Accelerating Kids’ Access to Care Act of 2025
2026 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1509
Accelerating Kids’ Access to Care Act
2026 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Client expense: — · Firm income: $60,000
Matched citations: S.752
Accelerating Kids’ Access to Care Act
2026 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Client expense: — · Firm income: $60,000
Matched citations: S.752
Accelerating Kids’ Access to Care Act of 2025
2025 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1509
Accelerating Kids’ Access to Care Act of 2025
2025 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1509
Accelerating Kids’ Access to Care Act
2025 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Client expense: — · Firm income: $60,000
Matched citations: S.752
Accelerating Kids’ Access to Care Act
2025 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Client expense: — · Firm income: $60,000
Matched citations: S.752
Accelerating Kids’ Access to Care Act of 2025
2025 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1509
Accelerating Kids’ Access to Care Act of 2025
2025 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1509
Accelerating Kids’ Access to Care Act
2025 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Client expense: — · Firm income: $60,000
Matched citations: S.752
Accelerating Kids’ Access to Care Act
2025 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Client expense: — · Firm income: $60,000
Matched citations: S.752
Accelerating Kids’ Access to Care Act of 2025
2025 · second_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development. Issues related to health coverage and patient access to care.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1509
Accelerating Kids’ Access to Care Act of 2025
2025 · second_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1509
Accelerating Kids’ Access to Care Act
2025 · second_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development. Issues related to health coverage and patient access to care.
Client expense: — · Firm income: $60,000
Matched citations: S.752
Accelerating Kids’ Access to Care Act
2025 · second_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Client expense: — · Firm income: $60,000
Matched citations: S.752
Accelerating Kids’ Access to Care Act of 2025
2025 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1509
Accelerating Kids’ Access to Care Act of 2025
2025 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1509
Accelerating Kids’ Access to Care Act
2025 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Client expense: — · Firm income: $60,000
Matched citations: S.752
Accelerating Kids’ Access to Care Act
2025 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act.
Client expense: — · Firm income: $60,000
Matched citations: S.752
Passport Assistance for Disadvantaged Students Act of 2019
2024 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to the No Surprises Act (Public Law 116-260) and patient protections. Issues related to agency funding for medical and cancer research. Issues related to H.R.4758/S.2372, The Accelerating Kids' Access to Care Act. Issues related to clinical trial diversity, including H.R. 3503/S.1701, The NIH Clinical Trial Diversity Act. Issues related to the pharmaceutical supply chain and drug shortages. Issues related to pediatric drug development.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 3503
Sexual Assault Victims Protection Act of 2019
2024 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to the No Surprises Act (Public Law 116-260) and patient protections. Issues related to agency funding for medical and cancer research. Issues related to H.R.4758/S.2372, The Accelerating Kids' Access to Care Act. Issues related to clinical trial diversity, including H.R. 3503/S.1701, The NIH Clinical Trial Diversity Act. Issues related to the pharmaceutical supply chain and drug shortages. Issues related to pediatric drug development.
Client expense: — · Firm income: $60,000
Matched citations: H.R.4758
Steel Industry Preservation Act
2024 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations. Issues related to the implementation of the Medicare Part D cap and smoothing provisions in the Inflation Reduction Act (Public Law 117-169). Issues related to H.R. 4758/S.2372, The Accelerating Kids' Access to Care Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4758
Stop Higher Education Espionage and Theft Act of 2019
2024 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to the No Surprises Act (Public Law 116-260) and patient protections. Issues related to agency funding for medical and cancer research. Issues related to H.R.4758/S.2372, The Accelerating Kids' Access to Care Act. Issues related to clinical trial diversity, including H.R. 3503/S.1701, The NIH Clinical Trial Diversity Act. Issues related to the pharmaceutical supply chain and drug shortages. Issues related to pediatric drug development.
Client expense: — · Firm income: $60,000
Matched citations: S.1701
Save Our Seas 2.0: Enhanced Global Engagement to Combat Marine Debris Act
2024 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to the No Surprises Act (Public Law 116-260) and patient protections. Issues related to agency funding for medical and cancer research. Issues related to H.R.4758/S.2372, The Accelerating Kids' Access to Care Act. Issues related to clinical trial diversity, including H.R. 3503/S.1701, The NIH Clinical Trial Diversity Act. Issues related to the pharmaceutical supply chain and drug shortages. Issues related to pediatric drug development.
Client expense: — · Firm income: $60,000
Matched citations: S.2372
Source: Senate LDA